AAA August 2016 – Page 11

Assurex explores Myriad possibilities in $410m acquisition

Molecular diagnostics equipment provider Myriad Genetics has agreed to acquire US-based precision medicine developer Assurex Health in a deal that will enable Mayo Clinic and Cincinnati Children’s Hospital Medical Center to exit. Myriad will pay $225m upfront and could provide up to $185m in performance-based milestones. Assurex’s lead product, GeneSight Psychotropic, evaluates 12 genes that… Continue reading Assurex explores Myriad possibilities in $410m acquisition